미국 · 보도자료 · MRNA · 2026-09-30 11:00
항암 분야 사업 확장에 따라 최고운영책임자(COO) 직책 신설
Moderna, Inc. (NASDAQ:MRNA) today announced the addition of a Chief Operating Officer role to support the increasing scale and diversification of the Company. The new role comes as Moderna prepares for the potential launch and scale-up of intismeran autogene following positive Phase 3 results and continues to advance a broader oncology portfolio. The Company has also expanded the infectious diseas
